Sara Valdeolivas

805 total citations
12 papers, 612 citations indexed

About

Sara Valdeolivas is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Neurology. According to data from OpenAlex, Sara Valdeolivas has authored 12 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 9 papers in Pharmacology and 3 papers in Neurology. Recurrent topics in Sara Valdeolivas's work include Cannabis and Cannabinoid Research (9 papers), Genetic Neurodegenerative Diseases (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). Sara Valdeolivas is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Genetic Neurodegenerative Diseases (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). Sara Valdeolivas collaborates with scholars based in Spain, United States and Italy. Sara Valdeolivas's co-authors include Onintza Sagredo, Javier Fernández‐Ruíz, M. Ruth Pazos, Irene Cantarero, María L. Bellido, Carmen Navarrete, Eduardo Muñóz, Valentina Satta, Manuel Guzmán and Roger G. Pertwee and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Sara Valdeolivas

12 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Valdeolivas Spain 10 472 346 106 102 97 12 612
Cristina Palomo‐Garo Spain 8 562 1.2× 400 1.2× 120 1.1× 55 0.5× 115 1.2× 8 671
R. Mechoulam Israel 5 363 0.8× 199 0.6× 65 0.6× 80 0.8× 63 0.6× 7 487
Andrea Burnett United States 3 632 1.3× 326 0.9× 165 1.6× 45 0.4× 100 1.0× 4 721
Camille Soubrane United Kingdom 4 266 0.6× 188 0.5× 61 0.6× 65 0.6× 49 0.5× 5 406
A. Aracil-Fernández Spain 12 528 1.1× 492 1.4× 126 1.2× 84 0.8× 31 0.3× 17 717
B. Emmanuel Akinshola United States 10 760 1.6× 636 1.8× 180 1.7× 96 0.9× 80 0.8× 16 900
Belén Ferrer Spain 8 781 1.7× 514 1.5× 179 1.7× 62 0.6× 53 0.5× 10 938
Alison J. Drysdale United Kingdom 6 360 0.8× 224 0.6× 90 0.8× 66 0.6× 78 0.8× 7 441
G. Patrick United States 7 282 0.6× 239 0.7× 51 0.5× 113 1.1× 28 0.3× 9 456
Kent‐Olov Jonsson Sweden 10 625 1.3× 211 0.6× 63 0.6× 137 1.3× 109 1.1× 10 743

Countries citing papers authored by Sara Valdeolivas

Since Specialization
Citations

This map shows the geographic impact of Sara Valdeolivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Valdeolivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Valdeolivas more than expected).

Fields of papers citing papers by Sara Valdeolivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Valdeolivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Valdeolivas. The network helps show where Sara Valdeolivas may publish in the future.

Co-authorship network of co-authors of Sara Valdeolivas

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Valdeolivas. A scholar is included among the top collaborators of Sara Valdeolivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Valdeolivas. Sara Valdeolivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rodríguez‐Cueto, Carmen, Mariluz Hernández, Cecilia J. Hillard, et al.. (2017). Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3. PLoS ONE. 12(4). e0176521–e0176521. 5 indexed citations
2.
Valdeolivas, Sara, Onintza Sagredo, Mercedes Delgado, Miguel A. Pozo, & Javier Fernández‐Ruíz. (2017). Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease. International Journal of Molecular Sciences. 18(4). 684–684. 26 indexed citations
3.
Rodríguez‐Cueto, Carmen, Mariluz Hernández, Cecilia J. Hillard, et al.. (2016). Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. Neuroscience. 339. 191–209. 21 indexed citations
4.
López-Sendón, José Luis, Juan García Caldentey, Patricia Trigo Cubillo, et al.. (2016). A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease. Journal of Neurology. 263(7). 1390–1400. 110 indexed citations
5.
Valdeolivas, Sara, Fabiana Piscitelli, Roberta Verde, et al.. (2016). Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome. Pharmacology Research & Perspectives. 4(2). e00220–e00220. 15 indexed citations
6.
Satta, Valentina, Myriam Calle Rubio, Sara Valdeolivas, et al.. (2016). Possible dysregulation of the endocannabinoid system in a cohort of patients with Dravet syndrome. European Neuropsychopharmacology. 26. S251–S251. 1 indexed citations
7.
Ooms, Maarten, Janaki Raman Rangarajan, Kathleen Vunckx, et al.. (2014). Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice. Neurobiology of Aging. 35(12). 2858–2869. 25 indexed citations
8.
Valdeolivas, Sara, Carmen Navarrete, Irene Cantarero, et al.. (2014). Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. Neurotherapeutics. 12(1). 185–199. 111 indexed citations
9.
10.
Valdeolivas, Sara, Valentina Satta, Roger G. Pertwee, Javier Fernández‐Ruíz, & Onintza Sagredo. (2012). Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors. ACS Chemical Neuroscience. 3(5). 400–406. 75 indexed citations
11.
Sagredo, Onintza, M. Ruth Pazos, Sara Valdeolivas, & Javier Fernández‐Ruíz. (2011). Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease. PubMed. 7(1). 41–48. 58 indexed citations
12.
Fernández‐Ruíz, Javier, Miguel Moreno‐Martet, Carmen Rodríguez‐Cueto, et al.. (2011). Prospects for cannabinoid therapies in basal ganglia disorders. British Journal of Pharmacology. 163(7). 1365–1378. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Palomo‐Garo Breakdown of academic impact, for papers by R. Mechoulam Breakdown of academic impact, for papers by Andrea Burnett Breakdown of academic impact, for papers by Camille Soubrane Breakdown of academic impact, for papers by A. Aracil-Fernández Breakdown of academic impact, for papers by B. Emmanuel Akinshola Breakdown of academic impact, for papers by Belén Ferrer Breakdown of academic impact, for papers by Alison J. Drysdale Breakdown of academic impact, for papers by G. Patrick Breakdown of academic impact, for papers by Kent‐Olov Jonsson
Rankless by CCL
2026